Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/1998
08/19/1998EP0859000A1 Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof
08/19/1998EP0858807A2 Use of dopamine receptor antagonists in palliative tumor therapy
08/19/1998EP0858506A2 Genetic induction of receptors for targeted radiotherapy
08/19/1998EP0858467A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
08/19/1998EP0858466A1 Use of protein gax for treating cancer
08/19/1998EP0858465A2 Anti-tumoral protein
08/19/1998EP0858457A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
08/19/1998EP0858346A1 Expression of cyclin g1 in tumors
08/19/1998EP0858341A1 Combination therapy for advanced cancer comprising temozolomide and cisplatin
08/19/1998EP0858327A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
08/19/1998EP0733057A4 Origin of replication complex genes, proteins and methods
08/19/1998EP0703926B1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
08/19/1998EP0660936B1 Up-converting reporters for biological and other assays using laser excitation techniques
08/19/1998CN1190991A Human chemokine beta-11 and human chemokine alpha-1
08/19/1998CN1190888A Methods and compositions for inhibiting 5 'alpha'=reductase activity
08/19/1998CN1190586A Oral liquid for mammary gland disease
08/18/1998US5795965 Reshaped human to human interleukin-6 receptor
08/18/1998US5795958 Library of glyco-peptides useful for identification of cell adhesion inhibitors
08/18/1998US5795910 Method and compositions for inhibiting protein kinases
08/18/1998US5795909 DHA-pharmaceutical agent conjugates of taxanes
08/18/1998US5795883 Tocopherol or trolox group
08/18/1998US5795882 Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
08/18/1998US5795875 Therapeutic methods of using O-desulfated heparin derivatives
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795740 Pituitary differentiation factor and methods of use thereof
08/18/1998US5795580 Group B streptococcus type V polysaccharide-protein conjugate vaccines
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2036876C Derivatives having a naphthalenic structure; process for preparing the same and pharmaceutical compositions containing them
08/13/1998WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
08/13/1998WO1998035028A2 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998WO1998034958A1 O-sulfated bacterial polysaccharides
08/13/1998WO1998034952A2 Il-2 gene expression and delivery systems and uses
08/13/1998WO1998034921A1 Bicyclic inhibitors of protein farnesyl transferase
08/13/1998WO1998034918A1 Arylsulfonyl hydroxamic acid derivatives
08/13/1998WO1998034909A1 Bi-aromatic compounds, compositions containing them and uses
08/13/1998WO1998034642A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998WO1998034641A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998WO1998034634A1 Compositions and methods for inhibiting cellular proliferation
08/13/1998WO1998034631A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998WO1998034622A1 Methods for the administration of amifostine
08/13/1998WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998WO1998034613A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
08/13/1998WO1998034599A1 Microgranules containing cisplatin
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
08/13/1998WO1998004290A3 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
08/13/1998DE19705229A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
08/13/1998CA2625727A1 Methods for the administration of amifostine
08/13/1998CA2281699A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998CA2280945A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998CA2280274A1 Compositions and methods for inhibiting cellular proliferation
08/13/1998CA2280237A1 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998CA2280190A1 Il-2 gene expression and delivery systems and uses
08/13/1998CA2279995A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998CA2279531A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998CA2273895A1 Bicyclic inhibitors of protein farnesyl transferase
08/13/1998CA2253221A1 Bi-aromatic compounds, compositions containing them and uses
08/12/1998EP0857781A2 Human endoglingene promoter and use thereof
08/12/1998EP0857487A2 Combinations for prophylaxsis and/or treatment of benign prostatic hyperplasia containing a 17 beta-hydroxy steroid dehydrogenase (17bHSD) inhibitor and at least one further active ingredient
08/12/1998EP0857485A2 Use of acemannan for the treatment of multiple sclerosis and for the correction of malabsorption
08/12/1998EP0857210A1 Therapeutic antiangiogenic compositions and methods
08/12/1998EP0857175A1 Novel human cysteine protease
08/12/1998EP0857071A1 (radio) labelled biotin derivatives
08/12/1998EP0857068A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes
08/12/1998EP0825848A4 Novel collagen formulations
08/12/1998EP0741687B1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/12/1998EP0696275B1 Vitamin d amide derivatives
08/12/1998EP0686143B1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent
08/12/1998EP0642530B1 Derivatives of dolastatin
08/12/1998EP0629211B1 4-oxo-2-thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
08/12/1998EP0613379B1 Therapeutic compounds
08/12/1998CN1190394A Bicyclic-aromatic compound
08/12/1998CN1190389A Farnesyl transferase inhibitors, its preparation and medicine composition thereof
08/12/1998CN1190344A Use of 1, 2, 4-triazole derivative for manufacture of medicament for treatment of cancer
08/12/1998CN1190021A Chinese medicine preparation for cancer and its compounding process
08/11/1998US5792870 2-amino-3-aroyl-benzo β!thiophenes and methods for preparing and using same to produce 6-hdyroxy-2-(4-hydroxyphenyl)-3- 4-(2-aminoethoxy)-benzoyl!benzo β!thiophenes
08/11/1998US5792849 Polypeptides useful for the stimulation of glial cell (particularly, schwann cell) mitogenesis and treating glial cell tumors
08/11/1998US5792845 Nucleotides encoding angiostatin protein and method of use
08/11/1998US5792842 Ganglioside GM3 derivative having fluorine atom at 9-position of sialic acid and intermediates therefor
08/11/1998US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792756 Phosphonate nucleotide analog antiviral/antitumor agent for oral drug delivery
08/11/1998US5792752 Synergistic effect in cancer and leukemic cell growth inhibition when a site 1-selective compound is used in combination with a site 2-selective compound
08/11/1998US5792748 Method for inhibiting neoplastic disease in mammals
08/11/1998US5792744 Proteins from mammalian liver
08/11/1998US5792645 Protein-polycation nucleic acid complexes and methods of use
08/11/1998US5792626 Human interferon-inducible protein
08/11/1998US5792503 Production of isoflavone enriched fractions from soy protein extracts
08/11/1998US5792456 Mutant BR96 antibodies reactive with human carcinomas
08/11/1998US5792455 Anti-idiotypic antibody vaccines
08/11/1998CA2076589C Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same
08/06/1998WO1998034121A2 Isolated p27 protein and methods for its production and use
08/06/1998WO1998033921A1 Novel human cystatin-like protein
08/06/1998WO1998033919A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998033907A1 A tumor suppressor designated ts10q23.3
08/06/1998WO1998033904A2 An antisense oligonucleotide preparation method
08/06/1998WO1998033893A2 Ribozymes cleaving epidermal growth factor receptors
08/06/1998WO1998033891A1 Method for the production of selected lymphocytes
08/06/1998WO1998033818A1 Human anion channel
1 ... 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 ... 2211